Index S&P 500 P/E 39.37 EPS (ttm) 1.94 Insider Own 1.28% Shs Outstand 241.71M Perf Week 0.74%
Market Cap 17.97B Forward P/E 17.26 EPS next Y 4.43 Insider Trans -3.94% Shs Float 231.72M Perf Month -0.96%
Income 466.50M PEG 5.32 EPS next Q 1.02 Inst Own 98.34% Short Float 1.95% Perf Quarter 5.66%
Sales 3.96B P/S 4.54 EPS this Y 2.53% Inst Trans -9.74% Short Ratio 2.66 Perf Half Y 14.77%
Book/sh 19.84 P/B 3.86 EPS next Y 9.19% ROA 5.14% Short Interest 4.52M Perf Year -8.98%
Cash/sh 9.29 P/C 8.24 EPS next 5Y 7.40% ROE 9.20% 52W Range 64.02 - 86.74 Perf YTD 7.12%
Dividend Est. - P/FCF 18.93 EPS past 5Y - ROI 6.34% 52W High -11.76% Beta 1.02
Dividend TTM - Quick Ratio 3.29 Sales past 5Y 7.03% Gross Margin 53.65% 52W Low 19.56% ATR (14) 1.51
Dividend Ex-Date - Current Ratio 3.97 EPS Y/Y TTM -46.37% Oper. Margin 22.78% RSI (14) 51.68 Volatility 2.51% 1.82%
Employees 6990 Debt/Eq 0.53 Sales Y/Y TTM -2.37% Profit Margin 11.78% Recom 2.11 Target Price 85.86
Option/Short Yes / Yes LT Debt/Eq 0.52 EPS Q/Q -18.23% Payout 0.00% Rel Volume 1.20 Prev Close 75.91
Sales Surprise 1.60% EPS Surprise 5.34% Sales Q/Q -0.85% Earnings May 02 AMC Avg Volume 1.70M Price 76.54
SMA20 -0.01% SMA50 0.61% SMA200 4.45% Trades
Volume 2,028,653 Change 0.83%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-03-24 Upgrade Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade Needham
Hold → Buy
$95
Dec-07-22 Initiated RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated Mizuho
Buy
$75
Jul-20-22 Initiated UBS
Neutral
$73
Jul-20-22 Downgrade BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade BTIG Research
Buy → Neutral
Apr-25-22 Downgrade Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed Cowen
Outperform
$83
Oct-14-21 Initiated Redburn
Neutral
Jul-06-21 Upgrade Evercore ISI
In-line → Outperform
$78
Nov-20-20 Downgrade Needham
Buy → Hold
Nov-05-20 Reiterated Needham
Buy
$78 → $88
Jun-30-20 Upgrade Cowen
Market Perform → Outperform
$64
Jun-03-20 Upgrade Raymond James
Mkt Perform → Outperform
$62
Apr-30-20 Upgrade SVB Leerink
Mkt Perform → Outperform
$62
Apr-30-20 Reiterated Needham
Buy
$52 → $60
Apr-07-20 Upgrade Wells Fargo
Equal Weight → Overweight
$48
Show Previous Ratings
Today 12:40PM
12:29PM
11:54AM
10:51AM
09:43AM
07:17AM
Loading…
07:17AM
(Thomson Reuters StreetEvents)
May-02-24 09:59PM
08:58PM
08:00PM
05:45PM
05:10PM
04:40PM
04:07PM
(Associated Press Finance)
04:01PM
Apr-30-24 06:27AM
05:58PM
Loading…
Apr-29-24 05:58PM
04:05PM
11:44AM
09:16AM
Apr-25-24 10:01AM
Apr-22-24 05:45PM
Apr-21-24 08:30AM
Apr-19-24 11:30AM
09:00AM
Apr-17-24 11:01AM
Apr-15-24 05:45PM
Apr-12-24 10:45AM
Apr-11-24 02:07PM
09:15AM
Apr-08-24 05:45PM
09:00AM
Loading…
09:00AM
Apr-03-24 12:10PM
09:54AM
Apr-02-24 05:45PM
08:08AM
Mar-28-24 07:24AM
Mar-27-24 09:00AM
Mar-25-24 05:45PM
Mar-19-24 12:53PM
(The Wall Street Journal)
Mar-18-24 05:45PM
Mar-15-24 07:00PM
09:00AM
Mar-12-24 05:45PM
Mar-06-24 11:15AM
Mar-05-24 08:10AM
Mar-04-24 09:00AM
Feb-28-24 01:16AM
Feb-27-24 03:44PM
03:30PM
08:00AM
Feb-26-24 04:15PM
Feb-21-24 09:00AM
Feb-18-24 01:26PM
Feb-06-24 10:43AM
Feb-05-24 03:31PM
01:43PM
10:40AM
09:00AM
Feb-03-24 12:08AM
Feb-02-24 12:52PM
11:08AM
07:05AM
(Thomson Reuters StreetEvents)
Feb-01-24 05:35PM
05:30PM
05:21PM
04:45PM
04:10PM
(Associated Press Finance)
04:01PM
Jan-31-24 11:17AM
Jan-30-24 07:29PM
Jan-29-24 09:16AM
Jan-25-24 11:00AM
(The Wall Street Journal)
10:00AM
Jan-22-24 05:45PM
Jan-20-24 03:19PM
Jan-19-24 09:00AM
Jan-18-24 11:30AM
Jan-17-24 12:10PM
12:07PM
Jan-16-24 05:45PM
08:30AM
Jan-11-24 08:08AM
Jan-09-24 05:45PM
Jan-08-24 09:00AM
Jan-07-24 04:00PM
Jan-04-24 08:33AM
Jan-02-24 05:45PM
08:08AM
Dec-28-23 04:28AM
Dec-27-23 05:45PM
09:00AM
Dec-20-23 05:45PM
Dec-18-23 07:39AM
Dec-14-23 05:45PM
05:05PM
Dec-11-23 06:55AM
Dec-07-23 03:37AM
Dec-05-23 09:00AM
Dec-03-23 05:25AM
Dec-01-23 06:25AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment focuses on products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment offers the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GARRETT SCOTT T Director Mar 14 '24 Option Exercise 30.93 16,441 508,471 65,052 Mar 15 04:11 PM GARRETT SCOTT T Director Mar 14 '24 Sale 75.50 16,441 1,241,296 48,611 Mar 15 04:11 PM CRAWFORD SALLY Director Mar 08 '24 Option Exercise 26.74 9,039 241,703 141,966 Mar 11 06:41 PM CRAWFORD SALLY Director Mar 08 '24 Sale 76.40 9,039 690,607 132,927 Mar 11 06:41 PM Dockendorff Charles J Director Mar 08 '24 Sale 76.21 1,465 111,648 1,572 Mar 11 06:45 PM Oberton Karleen Marie Chief Financial Officer Jan 29 '24 Sale 75.00 14,940 1,120,500 103,916 Jan 30 04:08 PM Dockendorff Charles J Director Jan 02 '24 Option Exercise 38.44 7,551 290,260 17,482 Jan 04 04:09 PM Dockendorff Charles J Director Jan 02 '24 Sale 72.00 16,017 1,153,224 1,465 Jan 04 04:09 PM GARRETT SCOTT T Director Dec 11 '23 Sale 68.71 10,000 687,116 47,039 Dec 13 04:07 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Option Exercise 26.21 47,711 1,250,505 1,286,799 Dec 01 04:04 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Sale 70.41 47,711 3,359,188 1,239,088 Dec 01 04:04 PM Mitchell Essex D Div. President, GYN Surgical Nov 21 '23 Sale 71.85 7,500 538,890 12,827 Nov 24 04:02 PM GARRETT SCOTT T Director Jun 15 '23 Sale 79.72 10,000 797,240 57,039 Jun 20 05:03 PM Mitchell Essex D Div. President, GYN Surgical May 05 '23 Sale 83.73 2,390 200,115 7,212 May 09 04:18 PM
Index RUT P/E - EPS (ttm) -14.59 Insider Own 3.07% Shs Outstand 27.08M Perf Week -0.13%
Market Cap 427.86M Forward P/E 25.25 EPS next Y 0.63 Insider Trans 0.00% Shs Float 26.25M Perf Month -6.62%
Income -393.28M PEG - EPS next Q -0.04 Inst Own 89.20% Short Float 2.38% Perf Quarter -12.03%
Sales 766.26M P/S 0.56 EPS this Y -53.36% Inst Trans -0.42% Short Ratio 1.81 Perf Half Y 134.77%
Book/sh 15.12 P/B 1.04 EPS next Y 509.84% ROA -5.66% Short Interest 0.62M Perf Year 104.93%
Cash/sh 2.64 P/C 5.98 EPS next 5Y - ROE -13.80% 52W Range 6.52 - 20.91 Perf YTD -10.99%
Dividend Est. - P/FCF 17.35 EPS past 5Y 3.36% ROI -42.41% 52W High -24.44% Beta 1.99
Dividend TTM - Quick Ratio 2.32 Sales past 5Y -12.39% Gross Margin 58.07% 52W Low 142.33% ATR (14) 0.62
Dividend Ex-Date - Current Ratio 2.78 EPS Y/Y TTM -495.69% Oper. Margin -5.05% RSI (14) 46.42 Volatility 3.51% 3.27%
Employees 2600 Debt/Eq 1.27 Sales Y/Y TTM -16.15% Profit Margin -51.32% Recom 4.00 Target Price 16.00
Option/Short Yes / Yes LT Debt/Eq 1.26 EPS Q/Q -963.47% Payout - Rel Volume 0.42 Prev Close 15.83
Sales Surprise -46.92% EPS Surprise -20.00% Sales Q/Q -50.65% Earnings May 08 AMC Avg Volume 345.47K Price 15.80
SMA20 -1.03% SMA50 -5.76% SMA200 16.30% Trades
Volume 144,721 Change -0.19%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-16-23 Initiated Needham
Hold
Dec-21-22 Initiated Barclays
Underweight
$9
Jun-17-22 Initiated JP Morgan
Neutral
$20
Mar-18-22 Initiated Guggenheim
Neutral
Apr-24-24 04:05PM
Apr-01-24 08:00AM
Mar-27-24 08:00AM
Mar-15-24 06:37AM
Feb-29-24 09:34AM
06:34AM
Loading…
06:34AM
(Thomson Reuters StreetEvents)
Feb-28-24 07:30PM
04:42PM
04:05PM
Feb-21-24 05:00PM
Feb-07-24 04:05PM
Dec-18-23 08:00AM
05:53AM
Dec-17-23 05:05AM
Dec-13-23 05:55AM
08:00AM
Loading…
Dec-12-23 08:00AM
Nov-03-23 06:08AM
Nov-02-23 12:57PM
06:52AM
(Thomson Reuters StreetEvents)
12:00AM
Nov-01-23 04:05PM
Oct-31-23 08:00AM
Oct-30-23 07:33AM
Oct-24-23 08:00AM
Oct-18-23 07:32PM
Oct-17-23 08:30AM
Oct-12-23 11:58AM
Oct-11-23 04:05PM
Oct-10-23 08:30AM
Sep-26-23 08:00AM
07:39AM
Loading…
Sep-11-23 07:39AM
Aug-17-23 08:00AM
Aug-10-23 08:50AM
08:00AM
Aug-06-23 10:22AM
Aug-02-23 11:00PM
05:35PM
04:05PM
Jul-18-23 08:37AM
Jul-12-23 04:05PM
Jun-02-23 12:36AM
May-22-23 04:05PM
May-04-23 06:33AM
(Thomson Reuters StreetEvents) +22.44%
02:00AM
May-03-23 05:55PM
04:05PM
Apr-27-23 08:30AM
Apr-18-23 08:21AM
Apr-13-23 08:30AM
Apr-12-23 04:10PM
Apr-03-23 09:00AM
Mar-23-23 08:30AM
Mar-15-23 08:30AM
Mar-10-23 05:42AM
Mar-07-23 07:50AM
Mar-03-23 06:56PM
Mar-02-23 04:07PM
06:29AM
(Thomson Reuters StreetEvents)
Mar-01-23 08:30PM
04:05PM
Feb-27-23 06:16AM
Feb-23-23 08:30AM
Feb-13-23 04:10PM
Jan-31-23 06:06AM
Jan-30-23 04:10PM
01:25PM
Dec-28-22 09:00AM
Dec-06-22 07:59AM
Nov-09-22 09:30PM
04:05PM
Nov-03-22 08:30AM
Oct-19-22 04:10PM
Oct-11-22 09:00AM
Aug-29-22 04:10PM
Aug-10-22 04:05PM
Aug-08-22 11:24AM
Jul-20-22 04:10PM
Jul-12-22 08:00AM
Jun-16-22 08:00AM
May-16-22 11:51AM
May-05-22 04:05PM
Apr-12-22 04:05PM
Mar-31-22 04:05PM
Mar-24-22 12:54PM
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and Dental Products segments. The Spine Products segment offers spinal surgery solutions such as implants, instrumentation, biologics, and bone healing technologies to treat patients with back or neck pain caused by degenerative conditions, deformities, tumors or traumatic injury of the spine. The Dental Products segment provides dental implant solutions, biomaterial solutions, and digital dentistry. The company was founded on November 4, 2021 and is headquartered in Westminster, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Jamali Vafa See remarks below. Apr 01 '24 Option Exercise 0.00 21,331 0 259,924 Apr 03 04:04 PM Whitney Rebecca Ann See remarks below. Mar 29 '24 Option Exercise 0.00 9,677 0 42,706 Apr 02 04:01 PM Jamali Vafa See remarks below. Mar 10 '24 Option Exercise 0.00 20,816 0 247,700 Mar 11 05:31 PM Heppenstall Richard See remarks below. Mar 10 '24 Option Exercise 0.00 6,939 0 81,235 Mar 11 05:32 PM Kanaglekar Indraneel See remarks below. Mar 10 '24 Option Exercise 0.00 4,163 0 34,085 Mar 11 05:32 PM Kidwell Heather See remarks below. Mar 10 '24 Option Exercise 0.00 2,776 0 60,046 Mar 11 05:32 PM Whitney Rebecca Ann See remarks below. Mar 10 '24 Option Exercise 0.00 4,163 0 34,226 Mar 11 05:30 PM Schneider Sandra Chief Accounting Officer Mar 10 '24 Option Exercise 0.00 3,591 0 17,474 Mar 11 05:31 PM Kanaglekar Indraneel See remarks below. Dec 28 '23 Option Exercise 0.00 25,598 0 36,864 Jan 02 05:01 PM Jamali Vafa See remarks below. Dec 28 '23 Option Exercise 0.00 127,987 0 297,942 Jan 02 05:02 PM Whitney Rebecca Ann See remarks below. Dec 28 '23 Option Exercise 0.00 25,598 0 38,941 Jan 02 05:02 PM Heppenstall Richard See remarks below. Dec 28 '23 Option Exercise 0.00 42,663 0 85,662 Jan 02 05:02 PM Kidwell Heather See remarks below. Dec 28 '23 Option Exercise 0.00 17,065 0 63,831 Jan 02 05:01 PM Schneider Sandra Chief Accounting Officer Dec 28 '23 Option Exercise 0.00 14,719 0 17,468 Jan 02 05:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
